实用医学杂志 ›› 2021, Vol. 37 ›› Issue (22): 2840-2844.doi: 10.3969/j.issn.1006⁃5725.2021.22.003

• 基础研究 • 上一篇    下一篇

ETAR-C58多肽生物合成及其对黑色素瘤A375细胞迁移和侵袭的影响

张飞飞1 张梦2 王中山1   

  1. 1 徐州医科大学麻醉学院,江苏省麻醉学重点实验室(江苏徐州 221004);2 徐州市中心医院,东南大学附属 医院妇产科(江苏徐州 221009)

  • 出版日期:2021-11-25 发布日期:2021-11-25
  • 通讯作者: 王中山 E⁃mail:wzs852@126.com
  • 基金资助:
    国家自然科学基金(编号:81600969)

Biosynthesis of ETAR ⁃ C58 peptide and its effects on migration and invasion of melanoma A375 cells

ZHANG Feifei*,ZHANG Meng,WANG Zhongshan.   

  1. Jiangsu Provincical Key Laboratory of Anesthesiology,College of Anesthesiology,Xuzhou Medical University,Xuzhou 221004,China

  • Online:2021-11-25 Published:2021-11-25
  • Contact: WANG Zhongshan E⁃mail:wzx852@126.com

摘要:

目的 获得 ETAR 羧基末端 58 个氨基酸的多肽(ETAR⁃C58),探讨其对黑色素瘤 A375 细胞 迁移和侵袭的影响。方法 通过 PCR 方法获得 ETAR⁃C58 碱基序列,将其克隆到原核表达载体 pWaldo⁃ GFPe,转化到大肠杆菌 BL21(DE3),诱导表达后,经镍柱亲和层析和分子筛层析,得到重组融合多肽,SDS⁃ PAGE 分析多肽表达量和纯度,免疫印迹做进一步的鉴定。最后采用 Transwell 法测定 A375 细胞的迁移 和侵袭能力。结果 成功构建了重组表达载体 pWaldo⁃ETAR⁃C58,优化表达条件获得了约 90%的可溶性 蛋白表达量,纯化获得纯度高达 95%的融合多肽,免疫印迹的曝光条带和重组多肽的大小相一致,加入 2 μmol/L ETAR⁃C58 后,A375 细胞的迁移和侵袭能力显著下降(P < 0.05)。结论 ETAR⁃C58 多肽具有抗 黑色素瘤的活性,为下一步的临床应用奠定了良好的基础。

关键词:

ETAR 羧基末端, 原核表达, 黑色素瘤, 细胞迁移, 细胞侵袭

Abstract:

Objective To obtain the 58 amino acid peptide of the carboxyl terminal of ETAR(ETAR ⁃ C58)and investigate the effects on the migration and invasion of melanoma A375 cells. Methods ETAR ⁃C58 sequence was amplified by PCR,inserted into the vector pWaldo⁃GFPe and then transformed into Escherichia coli BL21(DE3). After expression,the fusion peptide was purified by nickel column affinity chromatography and gel filtration chromatography,analyzed by SDS ⁃PAGE and further identified by immunoblotting. Finally,Transwell assay was carried out to measure the migration and invasion of A375cells. Results The recombinant expression vector pWaldo⁃ETAR⁃C58 was successfully constructed and the soluble fusion peptide was accounted for approxi⁃ mately 90%. SDS⁃PAGE and immunoblotting results verified the successful purification of the ETAR⁃C58 with nearly 95% purity. ETAR ⁃ C58 peptide could inhibit A375 cell migration and invasion at 2 μmol/L. Conclusion The ETAR⁃C58 peptide have anti⁃melanoma activity,which allows a possibility for further clinical application.

Key words:

ETAR carboxyl terminal, prokaryotic expression, melanoma, cell migration, cell invasion